Call for the use of the ILAE terminology for seizures and epilepsies by health care professionals and regulatory agencies to benefit patients and caregivers.
Stėphane AuvinAlexis A ArzimanoglouIsabella BrambillaJacqueline A FrenchKelly G KnuppLieven LagaeEmilio PeruccaEugen TrinkaDennis DlugosPublished in: Epilepsia (2023)
The International League Against Epilepsy (ILAE) introduced a classification for seizure types in 2017 and updated the classification for epilepsy syndromes in 2022. These classifications aim to improve communication among healthcare professionals and help patients better describe their condition. So far, regulatory agencies have used different terminology. This paper stresses the crucial need for consistently adopting ILAE terminology in both regulatory processes and clinical practice. It highlights how language plays a significant role in healthcare communication and how standardized terminology can enhance patient comprehension. The ongoing review of guidelines by regulatory bodies offers a timely opportunity. Aligning regulatory terminologies holds the potential to facilitate discussions on future drug development and harmonize practices across diverse regions, ultimately fostering improved care and research outcomes in epilepsy treatment.
Keyphrases
- healthcare
- end stage renal disease
- transcription factor
- clinical practice
- ejection fraction
- newly diagnosed
- machine learning
- chronic kidney disease
- palliative care
- peritoneal dialysis
- deep learning
- prognostic factors
- primary care
- social media
- climate change
- quality improvement
- risk assessment
- temporal lobe epilepsy
- replacement therapy
- current status